Last update 28 Aug 2025

Sonrotoclax

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BG-71332, BGB 11417, BGB-11417
Target
Action
inhibitors
Mechanism
Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States), Priority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC49H59N7O7S
InChIKeyZQTKOYMWCCSKON-XKXNWSITSA-N
CAS Registry2383086-06-2

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mantle-Cell LymphomaNDA/BLA
China
12 May 2025
Chronic Lymphocytic LeukemiaNDA/BLA
China
29 Apr 2025
Small Lymphocytic LymphomaNDA/BLA
China
29 Apr 2025
Recurrent Chronic Lymphoid LeukemiaPhase 3
United States
11 Jun 2025
Recurrent Chronic Lymphoid LeukemiaPhase 3
China
11 Jun 2025
Recurrent Chronic Lymphoid LeukemiaPhase 3
Argentina
11 Jun 2025
Recurrent Chronic Lymphoid LeukemiaPhase 3
Australia
11 Jun 2025
Recurrent Chronic Lymphoid LeukemiaPhase 3
Austria
11 Jun 2025
Recurrent Chronic Lymphoid LeukemiaPhase 3
Belgium
11 Jun 2025
Recurrent Chronic Lymphoid LeukemiaPhase 3
Brazil
11 Jun 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
47
prywfhahvn(acestdrqfs) = iriynddmcv kzepgjxmsx (mkbljjatkl )
Positive
14 May 2025
Phase 3
49
shqtgkbgkt(jjhvnvdequ) = not reached zsixcnmzuq (fbklejbhcy )
Positive
14 May 2025
Phase 1/2
79
Sonrotoclax + Azacitidine
ejphtaajyj(wwnjzwxgap) = mosalfxzqp aolurawpmk (cshuqfdrpt )
-
14 May 2025
Phase 1/2
68
Sonrotoclax + Azacitidine
iaauuywalq(knagfdesiw) = nmezptelwx mfsxsvwdwx (uzgyidoxge )
Positive
14 May 2025
Phase 1
23
gkkqdnnxme(fktotrqexn) = COVID-19 (n=8; 34.8%) xudmmjkajn (claztvexkp )
-
14 May 2025
Phase 1
64
djnrbraslw(xvgagruzdt) = not reached up to 640 mg once daily iyuvwgjobg (wnawqpglkw )
Positive
14 May 2025
Phase 1
Recurrent Chronic Lymphoid Leukemia
del(17p) | unmutated IGHV genes
18
sbnqljpdue(imfpqqisfp) = dquakajpij ecotzgamrq (fxhhcjyont )
Positive
14 May 2025
sbnqljpdue(imfpqqisfp) = mhikjowtkv ecotzgamrq (fxhhcjyont )
Phase 1/2
Multiple Myeloma
t(11;14)-positive
50
mindvwkphu(doqgkfvivf) = occurred in 5 pts (35.7%) in the 320-mg cohort and 17 pts (47.2%) in the 640-mg cohort vlnjzqygnh (ykoquowvye )
Positive
14 May 2025
Phase 1
112
xwbazrfaci(klnvwhjauo) = neutropenia (41%), contusion (38%), COVID-19 (30%), and diarrhea (29%; 78% had grade 1 events). Neutropenia was the most common grade ≥3 TEAE (n=29, 26%). hmnnlrpcuz (huoibuxifz )
Positive
09 Dec 2024
Phase 1
17
ykorjszhur(oigmwfgrcx) = occurred in ≥20% of patients who received sonrotoclax were anemia (n=6, 35%), COVID-19 (n=6, 35%), pyrexia (n=5, 29%), neutropenia (n=4, 24%), and pruritus(n=4, 24%). Anemia was the most common grade ≥3 TEAE (n=4; 24%). xuuthlriay (wylqhbrjwr )
Positive
14 May 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free